Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner
- 31 August 2011
- journal article
- research article
- Published by Elsevier BV in Neuropharmacology
- Vol. 61 (1-2), 262-267
- https://doi.org/10.1016/j.neuropharm.2011.04.010
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia—sub-chronic and early postnatal PCP treatment in attentional set-shiftingPsychopharmacology, 2009
- Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophreniaPharmacology Biochemistry and Behavior, 2008
- Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the ratPsychopharmacology, 2008
- D-Serine Augments NMDA-NR2B Receptor-Dependent Hippocampal Long-Term Depression and Spatial Reversal LearningNeuropsychopharmacology, 2007
- Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of AntipsychoticNeuropsychopharmacology, 2005
- Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophreniaPsychopharmacology, 2005
- Localization of the GLYT1 Glycine Transporter at Glutamatergic Synapses in the Rat BrainCerebral Cortex, 2004
- Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of SchizophreniaAnnals of the New York Academy of Sciences, 2003
- Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the RatJournal of Neuroscience, 2000
- GlycineB antagonists as potential therapeutic agentsAmino Acids, 1998